sermorelin

Human growth hormone (HGH) levels peak in adolescence through early adulthood and start to rapidly decline after the age of 30.  This decline is associated with an increase in body fat, loss of muscle mass, thinning of the skin, cognitive decline, and increased risk for cardiovascular disease. There are numerous published studies that demonstrate that replacing HGH levels to the optimal range reduces these symptoms and increases overall quality of life.  Physicians are now using sermorelin and growth hormone releasing peptides (GHRP2 and GHRP6) to boost HGH levels in men and women as an alternative to injecting HGH which is expensive